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Endovascular repair of abdominal aortic aneurysm
reduces intraoperative cortisol and perioperative
morbidity
Sue Pearson, PhD,a Tiffany Hassen, MBBS,b J. Ian Spark, MB, MD, FRCS,c John Cabot, MBBS,b Prue
Cowled, PhD,b and Robert Fitridge, MS, FRACS,b Adelaide, South Australia; and Leeds, United Kingdom
Background: The release of catabolic stress hormones because of surgical trauma leads to a breakdown of fats, proteins,
and carbohydrate stores and interference with immune function. This can delay wound healing and may increase the risk
of systemic inflammatory response syndrome (SIRS)/sepsis and postoperative complications. Minimally invasive surgery
can attenuate this response. Our purpose was (1) to compare neuroendocrine responses in patients undergoing open
abdominal aneurysm repair with those in patients undergoing endovascular aneurysm repair (EVAR), (2) to compare the
incidence of SIRS/sepsis and all complications in these two groups, and (3) to look at the relationship between procedure
type, neuroendocrine response, and incidence of SIRS/sepsis and complications.
Methods: Forty-six patients who underwent open repair and 19 who underwent EVAR were studied. A baseline (T1)
24-hour urine save was undertaken in the week before admission, and a second 24-hour save (T2) commenced at
anesthetic induction to measure cortisol and catecholamines. The incidences of SIRS/sepsis and complications were
recorded.
Results: Significant (P< .001) increases in cortisol and adrenaline from T1 to T2 occurred in all patients. Controlling for
the type of anesthetic, the administration of exogenous inotropes, and -adrenoreceptor antagonists (-blockers), there
was a significant difference in cortisol (T2) associated with the type of procedure. Responses were greater in open patients
in comparison to EVAR patients (F3,61  5.0; P  .03). The incidence of SIRS (50% vs 32%), sepsis (26% vs 5%), and all
complications (76% vs 32%) was significantly (P < .02) higher in open than EVAR patients, respectively. Cortisol and
adrenaline measured for 24 hours, commencing at the time of induction, tended to be higher in patients with SIRS/sepsis
and all complications, but this did not reach significance.
Conclusions: An attenuated glucocorticoid surge characterizes the reduced stress response experienced by patients
undergoing EVAR compared with open abdominal aortic aneurysm repair. A reduction in the occurrence of SIRS is a
feature of a more favorable postoperative course after an endovascular approach. (J Vasc Surg 2005;41:919-25.)Conventional open surgery for abdominal aortic aneu-
rysm (AAA) carries a considerable risk of morbidity and
death.1 Endovascular aneurysm repair (EVAR) was intro-
duced early in the last decade for the treatment of infrarenal
AAA,2,3 and the apparently less invasive technique of trans-
femoral endovascular aneurysmmanagement has been used
with increasing frequency.4,5
Whereas recently published results for open surgical
repair have shown impressive reductions in postoperative
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doi:10.1016/j.jvs.2005.02.040mortality rates, as low as 2% to 5%,6-8 comparable to
mortality data for endovascular repair reported from pooled
series and multicenter registries,9-11 evidence for short-
term benefits of stent grafts continues to accumulate.12
Differences in the inflammatory response to endovascular
and open aneurysm repair have been demonstrated by
many authors,13,14 although the results between centers
are inconsistent with regard to individual markers of in-
flammation. It may be that whereas the mechanism by
which the inflammatory response is generated is different,
the activation of the inflammatory cascade results in a
similar scenario in both groups of patients.
Trauma to the body from a controlled surgical inter-
vention induces an inflammatory response and a neuroen-
docrine stress response. The local inflammatory response is
important for subsequent repair to tissues, and the stress
response can have profound effects on homeostasis. The
release of these catabolic stress hormones leads to a break-
down of fats, proteins, and carbohydrate stores and inter-
ference with immune function, which can delay wound
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considerable work has been done comparing the immuno-
logic response in patients undergoing EVAR and open
aneurysm surgery, there has been little examination of the
release of catabolic stress hormones in these two groups.
Modification of the immune response has proven difficult
in the management of sepsis; thus, stress hormones may
provide an alternative therapeutic target.
The aim of this study was, therefore, (1) to determine
whether there is a difference in the stress response in
patients undergoing open repair vs those undergoing en-
dovascular repair, (2) to determine whether endovascular
repair is associated with a lower incidence of the systemic
inflammatory response syndrome (SIRS), sepsis, and all
complications compared with open repair, and (3) to de-
termine whether there is a difference in the stress response
between patients with or without SIRS/sepsis and compli-
cations in the two treatment groups.
SUBJECTS AND METHODS
The study protocol was approved by the ethics com-
mittees of the Queen Elizabeth Hospital and Royal
Adelaide Hospital. All patients were provided with detailed
information regarding the study, and informed consent was
obtained. Patients with an aortic aneurysm of 5.5 cm or
more were eligible for the study. Preoperative moderate or
severe renal impairment (serum creatinine 0.210
mmol/L) and administration of corticosteroid medications
within 6 months before surgery were exclusion criteria.
Allocation to open or endovascular methods of repair was
not randomized but was determined by anatomic suitabil-
ity and surgeon preference. The patients in the open group
underwent traditional transperitoneal repair of the infrare-
nal AAA with either tube or bifurcated grafting, as judged
by the operating surgeon. The endovascular group under-
went placement of a Zenith (Cook Inc, Bloomington, Ind)
endograft or Excluder (WL Gore & Associates, Flagstaff,
Ariz) via bilateral groin incisions.
The study group consisted of 70 patients undergoing
AAA repair at the Queen Elizabeth Hospital and the Royal
Adelaide Hospital (Adelaide, South Australia). Five pa-
tients were excluded from the analysis because of incom-
plete urine saves. Of the remaining 65 patients, 46 under-
went open repair, and 19 underwent endovascular repair.
Intraoperative and postoperative antibiotic prophy-
laxis, consisting of a cephalosporin with or without genta-
micin with or without metronidazole, was administered to
all patients. Any subsequent antibiotic regimens were ad-
ministered according to clinical evidence of infection. Be-
cause there were different protocols at the two hospitals,
not all procedures were performed with a general anes-
thetic. Sixty procedures were performed by using a general
anesthetic with epidural analgesia, and six endovascular
procedures were performed with an epidural and sedation.
Postoperative analgesia was optimized in all cases. Early in
the postoperative course, analgesia was administered via the
epidural or intravenous routes. Subcutaneous and oral an-
algesia was later substituted. Management of unfavorablehemodynamic parameters was at the discretion of the anes-
thetist. The administration of exogenous adrenaline and
noradrenaline was documented.
Demographic data and medical history. All infor-
mation pertaining to the patients’ demographic and medi-
cal history was obtained at the time of consent and from the
medical records. This included age, sex, and marital status.
Surgical risk according to the American Society of Anesthe-
siologists (American Society of Anesthesiologists) physical
status classification was also recorded for each patient. This
classification ranges from I to V, with I representing a
healthy individual and V representing a patient in imminent
danger of dying.17 The Charlson Index of comorbidity was
used to assign each patient a comorbidity score. This index
assigns a weight to conditions expected to affect mortality.
The patient’s score is the sum of these weights.18 Other
information included procedure time and length of stay.
The number of surgical procedures of any type within the
last 20 years was also recorded.
Twenty-four hour urine saves were used to assess adre-
nal function. Patients were instructed on how to undertake
the first baseline (T1) urine save in the week before surgery.
A second 24-hour urine save was commenced at the time of
anesthetic induction (T2).
Biochemical assays. All biochemical assays were per-
formed at the Institute of Medical and Veterinary Science,
the Queen Elizabeth Hospital Division, Department of
Clinical Chemistry. A dilute acetic acid (33%) was added to
the urine save containers to preserve the catecholamines.
Assays were performed according to the following proto-
cols.
Urine free cortisol was measured on the Bayer ACS-
180 SE (Tarrytown, NY) automated immunoassay analyzer
by using a competitive chemiluminescent assay. Cortisol in
the sample competes with acridinium ester–labeled cortisol
for binding to a polyclonal rabbit anti-cortisol antibody
complex coupled to a solid phase. After a 5-minute incu-
bation, the solid phase is separated magnetically, and
chemiluminescence is generated by the addition of hydro-
gen peroxide in an alkaline environment. The cortisol con-
centration is inversely proportional to the light emitted and
is interpolated from a stored master curve.
Urine catecholamines (the biogenic amines noradren-
aline and adrenaline) were measured by high-performance
liquid chromatography after cation exchange and alumina
chromatography according to the method of Pillai,19 but
this was modified to use a phosphate/citrate pH 4.5mobile
phase. A series of commercially prepared standards were
analyzed simultaneously, and all samples included an inter-
nal standard to correct for procedural losses. Unknown
sample values were interpolated from a dose-
response relationship derived from the standards, and the
chromatograms were visually inspected for interference.
Interference may arise from the presence of certain thera-
peutic drugs but is usually detectable by visual inspection.
SIRS/sepsis and complications classification.
Clinical outcomes were evaluated on a daily basis and were
classified according to the presence or absence of SIRS as
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Society of Critical Care Medicine Consensus Conference
Committee20 (Table I) on any of the first five postoperative
days. Patients were similarly evaluated until hospital dis-
charge for the presence of sepsis, defined, according to the
2001 SCCM/ESICM/ACCP/ATS/SIS International
Sepsis Definitions Conference guidelines,21 as a systemic
inflammatory response in the presence of documented or
suspected infection. In accordance with these guidelines,
the presence of infection was determined by positive micro-
biologic culture or the strong suspicion of invasion by
microorganisms, on the basis of radiologic investigations.
Pulmonary consolidation, as indicated by radiograph or
computed tomography, was therefore considered as evi-
dence of infection, despite the absence of microbiologic
confirmation in some cases. The presence of a systemic or
local complication was classified according to the recom-
mendations of the Ad Hoc Committee on Reporting Stan-
dards, Society for Vascular Surgery/North American
Chapter, International Society for Cardiovascular Sur-
gery.22,23
Data analysis. Neuroendocrine measures are pre-
sented as absolute values in nanomoles per 24 hours.
Square-root transformations were applied to neuroendo-
crine data for the purpose of data analysis to normalize their
distribution. Paired-samples t tests were used to determine
changes in neuroendocrine responses from baseline to sur-
gery. Relationships between variables were examined by
using (1) Pearson product-moment correlations, (2) the
Student t test for normally distributed variables, and (3) 2
analysis for discrete variables. Univariate analysis of variance
was used to determine differences in intraoperative neu-
roendocrine responses related to the procedure type; con-
founding factors were entered in as covariates. All analyses
were performed by using SPSS version 10 (SPSS Inc,
Chicago, Ill).
RESULTS
Demographic and clinical profile
The demographic and clinical profile of the patient
groups is shown in Table II. Patient cohorts were compa-
rable with respect to age, sex, marital status, and burden of
comorbidities, as indicated by the American Society of
Table I. Criteria for the diagnosis of SIRS and sepsis
Condition Criteria
SIRS* Temperature 38°C or 36°C (rectal)
Heart rate 90 bpm
Respiratory rate 20 breaths/min or PaCO2 4.3 kPa
White blood cell count 12,000/L, 4000/L, or
10% immature (bands) forms
Sepsis SIRS with documented infection
SIRS, Systemic inflammatory response syndrome.
*Diagnosis required two or more criteria.Anesthesiologists status and the Charlson Index.Most patients were men; this reflects the higher incidence
of aneurysm disease in men. Patients undergoing EVAR,
however, were more likely to have had more prior opera-
tions. They also had a significantly shorter hospital stay.
Neuroendocrine responses
Identification of confounding variables. Prelimi-
nary analysis of the data sought to identify possible con-
founding effects of anesthetic type, administration of exog-
enous inotropes, and -adrenoreceptor antagonists (-
blockers). Cortisol (T2) and adrenaline (T2) responses
were significantly associated with the type of anesthetic. No
significant association was found between anesthetic type
and noradrenaline (Table III).
Twenty-seven patients received exogenous inotropes
either during surgery or in the immediate postoperative
period. The administration of exogenous inotropes was
associated with a significantly higher adrenaline excretion
in the first 24 hours from anesthetic induction (inotropes:
mean, 277.9 nmols/24 hrs; SE, 79.1; no inotropes: mean,
109.7 nmols/24 hrs; SE, 24.6; t63  2.8; P  .02). There
was no significant association with urinary free cortisol and
noradrenaline excretion.
Thirty-five patients (28 open procedures and 7 EVAR)
were receiving long-term -blockers before surgery, and 4
patients (3 open procedures and 1 EVAR) received
-blockers in the acute preoperative period (within 48
hours of surgery). Among the patients who did not receive
-blockers before surgery, none subsequently received
-blockers in the first 24 hours from induction. Three,
however were started on -blockers between 24 and 120
hours after induction. Twenty-eight patients received
-blockers during the 24 hours after induction. Most of
these patients (64%) had also been receiving -blockers
before surgery. There was no significant effect of acute
-blockade on neuroendocrine responses at T1 or T2.
There was, however, a significant association between
chronic -blocker administration and adrenaline (T2;
-blocked: mean, 264.4 nmols/24 hrs; SE, 65.1; not
-blocked: mean, 76.7 nmols/24 hrs; SE, 10.8; t59 
2.46; P .001). No other significant effects of -blockade
at the other time points were detected.
Changes in neuroendocrine responses from T1 to
T2. In all patients there was a significant increase in corti-
sol (t64  19.3; P  .001) and adrenaline (t64  6.5; P 
.001) from T1 to T2. There was no significant increase in
noradrenaline (Table IV).
Changes in neuroendocrine responses associated
with procedure type. Controlling for preoperative
chronic -blockade, anesthetic type, and inotrope admin-
istration, levels of cortisol (T2) were significantly greater in
patients undergoing open repair in comparison to those
undergoing EVAR (F4,60  6.01; P  .02; Fig 1). Al-
though adrenaline (T2) responses were higher in open
patients compared with EVAR patients, this difference was
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SIRS, sepsis, and all complications was significantly greater
in open repair patients in comparison to EVAR (Table VI).
Neuroendocrine (T2) responses in patients with SIRS/
sepsis and/or complications are shown in Tables VII and
VIII. The only significant difference occurred in adrenaline
(T2) excretion between patients with complications and
those without complications (t63  1.75; P  .03). This
analysis was repeated and inotropes were controlled for
because of an association between a higher complication
rate and the administration of exogenous inotropes (21
4.3; P  .03). Once inotropes were controlled for in the
analysis, the results were no longer significant (F2,62 2.3;
P  .13).
Given that one of the criteria for SIRS is a heart rate
exceeding 90 bpm (Table I), further analysis was performed
to determine whether the negative chronotropic effect of
-blockade may have influenced classification of SIRS.
There was no significant difference in the incidence of SIRS
among those who received -blockers compared with those
Table II. Clinical and demographic characteristics of the p
Variable Open (n  46)
Age (y) 68.9 (1.1)
Sex ratio (male:female) 41:5
Married (%) 35 (76.1%)
ASA status III 30 (65.2%)
Prior surgical episodes 1.4 (0.2)
Charlson Index 1.4 (0.17)
Operating time (min) 196 (5.7)
Hospital stay (d) 10.2 (0.5)
Results are reported as means with standard errors unless otherwise indicate
EVAR, Endovascular aneurysm repair; ASA, American Society of Anesthes
Table III. A comparison of neuroendocrine responses
commencing at the time of anesthetic induction in







(n  6) P value
Cortisol 1734.9 (85.1) 1083.5 (266.6) .007
Adrenaline 194.3 (40.3) 33.8 (10.8) .04
Noradrenaline 278.8 (22.7) 259.0 (75.6) .74
Data are means and standard errors.
Table IV. Neuroendocrine responses in all patients at T1
and T2 (n  65)
Neuroendocrine responses T1 T2 P value
Cortisol 370.0 (21.5) 1674.8 (83.8) .001
Adrenaline 31.3 (3.3) 179.5 (37.0) .001
Noradrenaline 243.6 (11.3) 277.0 (21.5) .14
Data are means and standard errors.who did not in either procedure cohort.DISCUSSION
AAA repair is associated with a systemic inflammatory
response due to both surgical trauma and ischemic reper-
fusion injury.24 The pathophysiology of this response is
complex, involving activated neutrophils, endothelial cells,
and macrophages25 as cellular effectors, and is mediated by
a cascade of cytokines,24 in addition to complement com-
ponents26 and leukotrienes.27
These inflammatory events can be recognized clinically
nt populations










Fig 1. Cortisol levels in open and endovascular aneurysm repair
(EVAR) groups.
Table V. Catecholamine responses at T2
Catecholamines Open (n  46) EVAR (n  19) P value
Adrenaline 226.2 (50.6) 66.5 (12.3) .18
Noradrenaline 273.5 (28.7) 285.5 (25.6) .19
Data are means and standard errors.
EVAR, Endovascular aneurysm repair.atieby the fulfillment of two or more SIRS criteria20 (Table I).
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ing the lack of specificity of this 1992 consensus definition
of SIRS,28-31 and suggestions have been made to enhance
its specificity and increase its clinical utility.32 For such
reasons, the 2001 SCCM/ESICM/ACCP/ATS/SIS In-
ternational Sepsis Definitions Conference revisited the con-
cept of SIRS and its definition. The validity of the SIRS
concept was reaffirmed; however, deficiencies in the defini-
tion were acknowledged. Despite this, the participants were
unable to propose a more satisfactory biochemical, immu-
nologic, or clinical diagnostic alternative.21 Until alterna-
tive methods of defining or grading SIRS are uniformly
adopted, this definition continues to be used, with an
awareness of its inherent weaknesses. It is reassuring that, in
the current study, -blockade did not significantly influ-
ence the classification of SIRS, despite its effect on heart
rate, one of the SIRS criteria.
This study demonstrates a significantly higher inci-
dence of SIRS/sepsis after open AAA repair compared with
the endovascular approach. Several studies have compared
the inflammatory responses associated with each method of
repair by using a variety of markers, with sometimes con-
flicting results. Inflammatory markers demonstrated to be
present at greater levels after the open approach compared
with EVAR include the proinflammatory cytokines inter-
Table VI. Incidence of SIRS/sepsis and complications
Variable Open (n  46) EVAR (n  19) P value
SIRS 23 (50%) 6 (31.6%) .02
Sepsis 12 (26.1%) 1 (5.3%) .01
Complications 35 (76.1%) 6 (31.6%) .001
SIRS, Systemic inflammatory response syndrome; EVAR, endovascular an-
eurysm repair.
Table VII. Neuroendocrine responses in patients with






(n  42) P value
Cortisol 1518.8 (122.9) 1760.2 (109.7) .16
Adrenaline 101.7 (20.4) 222.2 (55.3) .07
Noradrenaline 285.7 (30.2) 272.2 (29.2) .57
Data are means and standard errors.
SIRS, Systemic inflammatory response syndrome.
Table VIII. Neuroendocrine responses in patients with






(n  41) P value
Cortisol 1531.2 (132.9) 1758.9 (106.8) .16
Adrenaline 96.4 (19.1) 228.2 (56.5) .03
Noradrenaline 278.1 (27.3) 276.4 (30.4) .69
Data are means and standard errors.leukin 613,33,34 and interleukin 8,13 C-reactive pro-tein,33-35 indicators of T-lymphocyte activation,35,36 and
complement activation products.35 Conversely, Morikage
et al37 noted that levels of interleukin 6, C-reactive protein,
and granulocyte elastase and white blood cell counts were
higher among patients undergoing EVAR compared with
open repair. Hence, they concluded that EVAR provoked a
greater biological response. Other indicators of inflamma-
tory processes, including levels of neutrophil and platelet
degranulation products, have failed to distinguish between
the two approaches to aneurysm repair.34 Similarly,
Sweeney et al36 found that the use of SIRS criteria failed to
detect a difference between the two approaches to repair in
a small patient cohort.
We suggest that the current finding of a greater inci-
dence of SIRS with open repair among a larger cohort may
reflect a summation of the numerous proinflammatory and
anti-inflammatory events underlying each method of re-
pair. This may bemore clinically relevant than differences in
individual inflammatory markers. A greater inflammatory
response to open repair may reflect the extent of mechanical
tissue injury and the magnitude of ischemic reperfusion
injury. The greater incidence of complications after open
repair is consistent with the abundant literature on this
topic.
In considering the neuroendocrine response to sur-
gery, the finding of a greater adrenaline response among
chronically -blocked patients was unexpected. In a ran-
domized controlled trial designed to test the hypothesis
that -blockade attenuates catecholamine surges during
noncardiac surgery, Zaugg et al38 found that -blockade
did not alter the hormonal stress response. The present
finding may therefore not be a pharmacologic effect of
-blockade; rather, it may indicate that the patients receiv-
ing -blockers were more physiologically compromised
before surgery. The stress response to surgery among such
patients may therefore be exaggerated.
After controlling for potential confounding variables,
cortisol excretion was found to be significantly greater in
response to open aneurysm repair compared with the en-
dovascular technique. Although adrenaline responses were
greater in open-repair patients, this was not significant once
we controlled for the confounding effects of anesthetic
type, inotropes, and -blockade. Two previous studies have
examined the stress response to endovascular compared
with open repair,14,39 and both demonstrated greater in-
creases in adrenaline in the open cohort. Only one of these
considered the role of cortisol in this response14; it demon-
strated a significantly greater increase in plasma cortisol at
only a single time point after open compared with endovas-
cular repair. This study indicates that cortisol may be amore
important factor than previously recognized in characteriz-
ing a greater early stress response associated with open
repair. The finding that noradrenaline excretion did not
differ between the two procedure groups is consistent with
previous studies.14,39
This study, however, also sought to examine differ-
ences in the neuroendocrine responses between compli-
cated and uncomplicated cases. The observed association
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complications may indicate that the stress hormones are
early, nonspecific indicators of organ compromise. Al-
though controlling for exogenous inotrope administration
negates this finding, it remains unclear whether this poten-
tial confounding variable significantly influenced adrena-
line excretion or whether it is simply a marker of a more
physiologically compromised cohort.
The interaction between the immune and neuroendo-
crine systems is a critical determinant of the host’s response
to infectious and inflammatory challenges.40 Both glu-
cocorticoids and catecholamines induce a shift in cytokine
production from a primarily proinflammatory to an anti-
inflammatory pattern.40,41 Although these immunomodu-
latory functions are essential for homeostasis, overactiva-
tion of the neuroendocrine stress axis may render a host
immunosuppressed and susceptible to infectious disease.40
It would therefore seem reasonable to hypothesize that a
greater neuroendocrine stress response to surgery may ren-
der a patient less likely to develop systemic inflammation
but more susceptible to infectious complications. Results
from this study tend to refute this hypothesis, because the
occurrence of SIRS or sepsis was associated with a non–
statistically significant trend toward a greater neuroendo-
crine stress response. This finding may reflect that arm of
the neuroendocrine-immune regulatory loop in which
proinflammatory cytokines released in response to an insult
stimulate the hypothalamic-pituitary-adrenal axis, thus pro-
voking the release of glucocorticoids,42 rather than the
subsequent tempering influence of glucocorticoids on the
ensuing immune-inflammatory response. A distinction be-
tween the neuroendocrine response to SIRS compared
with sepsis, achieved through the involvement of a larger
patient cohort, may provide greater clarity to the under-
standing of the complex immune-neuroendocrine integra-
tion.
The apparent association of greater adrenaline excre-
tion and the occurrence of SIRS/sepsis would also seem at
odds with current evidence demonstrating catecholamine-
induced suppression of specific proinflammatory cyto-
kines.41 This inconsistency, however, may be explained by
the recognition that the influence of catecholamines on the
expression of individual cytokines compared with their
influence on the occurrence of SIRS or sepsis syndromes do
in fact reflect different, albeit related, end points.
There are several limitations to this study. Although it
was a prospective study, it was not randomized. At the time
of the study, all patients who did not meet the anatomic
criteria for an endovascular technique were placed in the
open group. It is possible that the more anatomically
challenging cases were treated in the open fashion. How-
ever, the cohorts were comparable with respect to their
burden of comorbidities. Furthermore, restricting the
pharmacologic methods of hemodynamic control would
eliminate the potential confounding effect of exogenous
catecholamine administration in this study. The inability to
rigorously standardize postoperative analgesia is considered
a limitation that may have influenced stress hormone pro-duction. Finally, as previously stated, patient numbers pre-
vented the separation of SIRS and sepsis as distinct end
points. A larger cohort enabling separation of these two
outcomes would provide further valuable insights.
REFERENCES
1. Berridge DC, Chamberlain J, Guy AJ, Lambert D. Prospective audit of
abdominal aortic aneurysm surgery in the northern region from 1988 to
1992. Northern Vascular Surgeons Group. Br J Surg 1995;82:906-10.
2. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
3. Volodos NL, Karpovich IP, Troyan VI, et al. Clinical experience of the
use of self-fixing synthetic prostheses for remote endoprosthetics of the
thoracic and the abdominal aorta and iliac arteries through the femoral
artery and as intraoperative endoprosthesis for aortic reconstruction.
Vasa 1991;33:93-5.
4. Kretschmer G, Lammer J, Polterauer P, et al. The first 15 months of
transluminal abdominal aortic aneurysm management: a single centre
experience. Eur J Vasc Endovasc Surg 1997;14:24-32.
5. Moore WS, Kashyap VS, Vescera CL, et al. Abdominal aortic aneurysm:
a 6-year comparison of endovascular versus transabdominal repair. Ann
Surg 1999;230:298-306.
6. Ernst CB. Abdominal aortic aneurysm. N Engl J Med 1993;328:1167-
72.
7. Feinglass J, Cowper D, Dunlop D, et al. Late survival risk factors for
abdominal aortic aneurysm repair: experience from fourteen Depart-
ment of Veterans Affairs hospitals. Surgery 1995;118:16-24.
8. Pfeiffer T, Reiher L, Grabitz K, et al. Results of conventional surgical
therapy of abdominal aortic aneurysms since the beginning of the
“endovascular era”. Chirurg 2000;71:72-9.
9. Buth J, Laheij RJ. Early complications and endoleaks after endovascular
abdominal aortic aneurysm repair: report of a multicenter study. J Vasc
Surg 2000;31:134-46.
10. EUROSTAR DRC. Progress report August 2000. Available at: URL:
http://www.evtoday.com/AAA/Aneurysm.html.
11. Holzenbein TJ, Kretschmer G, Polterauer P, et al. Midterm durability
of abdominal aortic aneurysm endograft repair: a word of caution. J
Vasc Surg 2001;33(Suppl 2):S46-54.
12. Maher MM, McNamara AM, MacEneaney PM, Sheehan SJ, Malone
DE. Abdominal aortic aneurysms: elective endovascular repair versus
conventional surgery—evaluation with evidence-based medicine tech-
niques. Radiology 2003;228:647-58.
13. Rowlands TE, Homer-Vanniasinkam S. Pro- and anti-inflammatory
cytokine release in open versus endovascular repair of abdominal aortic
aneurysm. Br J Surg 2001;88:1335-40.
14. Salatash K, Sternbergh WC, York JM, Money SR. Comparison of open
transabdominal AAA repair with endovascular AAA repair in reduction
of the postoperative stress response. Ann Vasc Surg 2001;15:53-9.
15. Arndt P, Abraham P. Immunological therapy in sepsis: experimental
therapies. Intensive Care Med 2001;27:S104-15.
16. Carlet J. Immunologic therapy in sepsis: currently available. Intensive
Care Med 2001;27:S93-103.
17. Sabiston DC. Textbook of surgery: the biological basis of modern
surgical practice. 13th ed. Philadelphia: WB Saunders Co; 1986.
18. Charlson ME, Pompei P, Ales KL, McKenzie RC. A new method of
classifying prognostic comorbidity in longitudinal studies: development
and validation. J Chronic Dis 1987;40:373-83.
19. Pillai DN. High performance liquid chromatography in the clinical
laboratory. In: Sampson DC, editor. The clinical biochemist (Novem-
ber monograph), NSW, Australian Association of Clinical Biochemists
(AACB); 1986. p. 54-6.
20. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.
Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. The ACCP/SCCM Consensus Confer-
ence Committee. American College of Chest Physicians/Society of
Critical Care Medicine. Chest 1992;101:1644-55.
JOURNAL OF VASCULAR SURGERY
Volume 41, Number 6 Pearson et al 92521. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al.
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defini-
tions Conference. Crit Care Med 2003;31:1250-6.
22. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK,
Bernhard VM, et al. Reporting standards for endovascular aneurysm
repair. J Vasc Surg 2002;35:1048-60.
23. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et
al. Recommended standards for reports dealing with lower extremity
ischemia: revised version. J Vasc Surg 1997;26:517-38.
24. Swartbol P, Truedsson L, Norgren L. The inflammatory response and
its consequence for the clinical outcome following aortic aneurysm
repair. Eur J Vasc Endovasc Surg 2001;21:393-400.
25. Davies MG, Hagen PO. Systemic inflammatory response syndrome.
Br J Surg 1997;84:920-35.
26. Bengtson A, Heideman M. Altered anaphylatoxin activity during in-
duced hypoperfusion in acute and elective abdominal aortic surgery.
J Trauma 1986;26:631-7.
27. Gadaleta D, Fantini GA, Silane MF, Davis JM. Neutrophil leukotriene
generation and pulmonary dysfunction after abdominal aortic aneurysm
repair. Surgery 1994;116:847-52.
28. Opal SM. The uncertain value of the definition for SIRS. Systemic
inflammatory response syndrome. Chest 1998;113:1442-3.
29. Pittet D, Rangel-Frausto S, Li N, Tarara D, CostiganM, Rempe L, et al.
Systemic inflammatory response syndrome, sepsis, severe sepsis and
septic shock: incidence, morbidities and outcomes in surgical ICU
patients. Intensive Care Med 1995;21:302-9.
30. Smail N, Messiah A, Edouard A, Descorps-Declere A, Duranteau J,
Vigue B, et al. Role of systemic inflammatory response syndrome and
infection in the occurrence of early multiple organ dysfunction syn-
drome following severe trauma. Intensive Care Med 1995;21:813-6.
31. Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. Crit Care
Med 1997;25:372-4.
32. Norwood MG, Bown MJ, Lloyd G, Bell PR, Sayers RD. The clinical
value of the systemic inflammatory response syndrome (SIRS) in ab-
dominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2004;27:
292-8.33. Bolke E, Jehle PM, Storck M, Braun C, Schams S, Steinbach G, et al.
Endovascular stent-graft placement versus conventional open surgery in
infrarenal aortic aneurysm: a prospective study on acute phase response
and clinical outcome. Clin Chim Acta 2001;314:203-7.
34. Odegard A, Lundbom J, Myhre HO. The inflammatory response
following treatment of AAA: a comparison between open surgery and
endovascular repair. Eur J Vasc Endovasc Surg 2000;19:536-44.
35. Galle C, De Maertelaer V, Motte S, Zhou L, Stordeur P, Delville JP, et
al. Early inflammatory response after elective abdominal aortic aneu-
rysm repair: a comparison between endovascular procedure and con-
ventional surgery. J Vasc Surg 2000;32:234-46.
36. Sweeney KJ, Evoy D, Sultan S, Coates C, Moore DJ, Shanik DG, et al.
Endovascular approach to abdominal aortic aneurysms limits the post-
operative systemic immune response. Eur J Vasc Endovasc Surg 2002;
23:303-8.
37. Morikage N, Esato K, Zenpo N, Fuliok K, Takenaka H. Is endovascular
treatment of aortic aneurysms less invasive regarding biological re-
sponses? Surg Today 2000;30:142-6.
38. Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et
al. Beneficial effects from beta-adrenergic blockade in elderly patients
undergoing noncardiac surgery. Anesthesiology 1999;91:1674-86.
39. Thompson JP, Boyle JR, ThompsonMM, Strupish J, Bell PR, Smith G.
Cardiovascular and catecholamine responses during endovascular and
conventional abdominal aortic aneurysm repair. Eur J Vasc Endovasc
Surg 1999;17:326-33.
40. Sternberg EM. Neuroendocrine regulation of autoimmune/inflamma-
tory disease. J Endocrinol 2001;169:429-35.
41. Elenkov IJ, Chrousos GP. Stress, cytokine patterns and susceptibility to
disease. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:583-
95.
42. Mulla A, Buckingham JC. Regulation of the hypothalamo-pituitary-
adrenal axis by cytokines. Baillieres Best Pract Res Clin Endocrinol
Metab 1999;13:503-21.Submitted Nov 25, 2004; accepted Feb 24, 2005.
